Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

BACKGROUND AND PURPOSE: Atomoxetine is a selective noradrenaline reuptake inhibitor, recently approved for the treatment of attention-deficit/hyperactivity disorder. So far, atomoxetine has been shown to be well tolerated, and cardiovascular effects were found to be negligible. However, two independ...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Scherer, Daniel, Hassel, David, Bloehs, Ramona, Zitron, Edgar, von Löwenstern, Katharina, Seyler, Claudia, Thomas, Dierk, Konrad, Franziska, Bürgers, Heiner F, Seemann, Gunnar, Rottbauer, Wolfgang, Katus, Hugo A, Karle, Christoph A, Scholz, Eberhard P
格式: Artigo
語言:Inglês
出版: Blackwell Publishing Ltd 2009
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697834/
https://ncbi.nlm.nih.gov/pubmed/19154426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2008.00018.x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍